129888-60-4

129888-60-4 structure

Name: N-Boc-3-mesyloxypiperidine
Chemical Name: N-Boc-3-mesyloxypiperidine
CAS Number: 129888-60-4
Molecular Formula: C₁₁H₂₁NO₅S
Molecular Weight: 279.353
Create Date: 2018-06-17 12:51:39
Modify Date: 2026-07-06 18:38:56

Name	N-Boc-3-mesyloxypiperidine
Synonyms	tert-Butyl 3-[(methylsulfonyloxy)]-1-piperidinecboxylate tert-Butyl 3-((methylsulfonyl) 2-Methyl-2-propanyl 3-[(methylsulfonyl)oxy]-1-piperidinecarboxylate tert-Butyl 3-Methylsulfonyloxypiperidine-1-carboxylate tert-Butyl 3-(methanesulfonyloxy)piperidine-1-cboxylate 1-Boc-3-methanesulphonyloxypiperidine tert-Butyl 3-Methylsulfonyloxypiperidine-1-cboxylate 3-((methylsulfonyl)oxy)piperidine-1-cboxylate tert-Butyl 3-[(methylsulfonyl)oxy]piperidine-1-carboxylate tert-Butyl 3-Methylsulfonyloxypiperidin-1-carboxylate N-BOC-3-(Methylsulfonyloxy)piperidine 1,1-Dimethylethyl 3-[(methylsulfonyl)oxy]-1-piperidinecboxylate 3-(Methylsulfonyloxy)piperidine-1-cboxylic acid tert-butyl ester tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate 1-Boc-3-methanesulfonyloxy-piper 1-Piperidinecboxylic acid, 3-[(Methylsulfonyl)oxy]-, 1,1-diMethylethyl ester 3-methylsulfonyloxy-1-piperidinecboxylic acid tert-butyl ester 3-methanesulfonyloxy-N-t-butoxycarbonylpiperidine 1-Piperidinecarboxylic acid, 3-[(methylsulfonyl)oxy]-, 1,1-dimethylethyl ester tert-Butyl 3-Methylsulfonyloxypiperidin-1-cboxylate tert-Butyl 3-[(methylsulfonyl)oxy]-1-piperidinecarboxylate 1-(tert-Butoxycbonyl)-3-(methanesulfonyloxy)piperidine 1-tert-butoxycarbonylpiperid-3-yl methanesulfonate

Density	1.2±0.1 g/cm3
Boiling Point	407.2±34.0 °C at 760 mmHg
Molecular Formula	C₁₁H₂₁NO₅S
Molecular Weight	279.353
Flash Point	200.1±25.7 °C
Exact Mass	279.114044
PSA	81.29000
LogP	0.64
Vapour Pressure	0.0±0.9 mmHg at 25°C
Index of Refraction	1.500

HS Code	2933399090

85275-45-2

124-63-0

~99%

129888-60-4

Literature: VERTEX PHARMACEUTICALS INCORPORATED; Charrier, Jean-Damien; Durrant, Steven John; Knegtel, Ronald Patent: US2013/115310 A1, 2013 ; Location in patent: Paragraph 0248; 0249 ;

85275-45-2

7143-01-3

~90%

129888-60-4

Literature: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.; HOPKINS, Brian, T.; SCOTT, Daniel; CONLON, Patrick; JENKINS, Tracy, J.; POWELL, Noel; GUAN, Bing; CURERVO, Julio, H.; WANG, Deping; TAVERAS, Art Patent: WO2012/58645 A1, 2012 ; Location in patent: Page/Page column 210 ; WO 2012/058645 A1

85275-45-2

124-63-0

121-44-8

~94%

129888-60-4

Literature: The United States of America as represented by the Department of Health and Human Services Patent: US5571832 A1, 1996 ; US 5571832 A

6859-99-0

129888-60-4

Literature: Journal of Medicinal Chemistry, , vol. 35, # 23 p. 4334 - 4343

24424-99-5

129888-60-4

Literature: Journal of Medicinal Chemistry, , vol. 35, # 23 p. 4334 - 4343

Precursor 6
85275-45-2 124-63-0 7143-01-3 121-44-8
6859-99-0 24424-99-5
DownStream 5
131667-57-7 85838-94-4 5810-55-9 129888-61-5
144243-24-3

HS Code	2933399090
Summary	2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1420869-94-8	1420998-12-4
1420847-33-1	1420863-19-9
1420841-51-5	1420832-82-1
1420896-75-8	1420799-25-2
1420873-31-9	1298085-55-8